This supplemental is being furnished in conjunction with the earnings release dated February 24, 2026 which contains reconciliations of Non-GAAP measures to Total Revenues and Total Hotel Operating Expenses on a consolidated GAAP basis for the three months and years ended December 31, 2025 and 2024. | TABLE OF CONTENTS | Page | | --- | --- | | (1) Same-Property Portfolio Data by Market, Ranked by Hotel EBITDA | 2 - 3 | | (1) Same-Property Portfolio Data by Market, for the Three Months and Years Ended Decemb ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 20-F (Mark One) o REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 OR o SHELL COMPANY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of event requiring ...

Exhibit 99.1 Planet Fitness, Inc. Announces Fourth Quarter and Year-End 2025 Results Full-year system-wide same club sales increase of 6.7% Net membership growth of 1.1 million in 2025 Opened 181 new Planet Fitness clubs in 2025 Hampton, NH, February 24, 2026 - Today, Planet Fitness, Inc. (NYSE: PLNT) reported financial results for its fourth quarter and year ended December 31, 2025. Fourth Quarter Fiscal 2025 Highlights Fiscal Year 2025 Highlights "We're pleased with our strong performance in 2025 that was ...

FOR IMMEDIATE RELEASE Investor Contact: Tiffany Kanaga (765) 740-0314 or tiffany.kanaga@elancoah.com Media Contact: Colleen Parr Dekker (317) 989-7011 or colleen.dekker@elancoah.com **Per Kynetec Q3 and Q4 data ***Internal estimates based on multiple data sources Elanco Animal Health Reports Fourth Quarter and Full Year 2025 Results Raising 2026 Innovation Target; Full Year 2026 Guidance of 4%-6% Organic Constant Currency Revenue Growth, 6%-9% Adjusted EBITDA Growth In Line with Investor Day Outlook Indiana ...

FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS FOURTH QUARTER AND FULL YEAR 2025 FINANCIAL RESULTS AND INTRODUCES 2026 FINANCIAL GUIDANCE MELVILLE, N.Y., February 24, 2026 – Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today reported financial results for the fourth quarter ended December 27, 2025. "Our fourth-quarter sales reflect continuing momentum resulting in the highest sales growth in 15 quarters. We are pleased ...

Fourth Quarter 2025 Sales for the fourth quarter of fiscal 2025 were $38.2 billion, a decrease of $1.5 billion, or 3.8% from the fourth quarter of fiscal 2024. The fourth quarter of fiscal 2025 consisted of 13 weeks compared with 14 weeks for the prior year. The 14th week in fiscal 2024 added approximately $2.5 billion of sales to the fourth quarter and the year. Comparable sales for the fourth quarter of fiscal 2025 increased 0.4%, and comparable sales in the U.S. increased 0.3%. Net earnings for the fourt ...

Financial Performance - Rental revenues decreased by 14% to $265.5 million in 2025 from $306.9 million in 2024[40] - Net income attributable to common stockholders fell by 28% to $114.4 million in 2025 compared to $159.9 million in 2024[40] - Adjusted funds from operations (AFFO) attributable to common stockholders decreased by 20% to $205.4 million in 2025 from $256.1 million in 2024[40] - The company declared dividends per share of $7.60 in 2025, a slight increase of 1% from $7.52 in 2024[40] Investments and Financing - The company committed to invest up to $170 million in IQHQ REIT, purchasing 50,000 shares of preferred stock for a total of $50 million[26][27] - The IQHQ Credit Facility has an initial term of three years with a fixed interest rate of 13.5%, including 12.0% payable in cash and 1.5% PIK[32] - As of December 31, 2025, the remaining balance of the company's committed investment in IQHQ Preferred Stock totaled $120 million, expected to be funded in multiple tranches[29] - The Revolving Credit Facility was increased from $50 million to $87.5 million in November 2024, with $27.5 million of borrowings outstanding as of December 31, 2025[45] - The company repurchased 371,538 shares of common stock for $20.1 million under a share repurchase program authorized in March 2025[42] - The IIP Life Science Credit Facility provides a revolving line of credit up to $100.0 million, with the potential to increase to $135.0 million under certain conditions, maturing on October 3, 2028[46] - As of December 31, 2025, the company had $75.0 million in borrowings under the IIP Life Science Credit Facility, with an interest rate of 6.1%[46] Property and Portfolio Management - The company owns 111 properties across 19 states, with a total rentable square footage of 8,565,000, and a contractual rent collected of $243.743 million for the year ended December 31, 2025[49] - The operating portfolio is 96.7% leased with a weighted-average remaining lease term of 12.8 years, subject to contractual rental rate increases[52] - As of December 31, 2025, the company derived rental revenues from 111 properties, with total invested and committed capital amounting to $1.5 billion and contractual rent collected of $171.7 million, representing 75% of total[77] - The top ten tenants accounted for 75% of total rental revenues, with Ascend Wellness Holdings, Inc. contributing 13% and PharmaCann Inc. contributing 4%[77] Market and Industry Trends - The regulated cannabis industry in the U.S. is projected to grow from $31.4 billion in 2024 to $44.4 billion by 2029, representing a compound annual growth rate of approximately 7.2%[61] - In 2025, worldwide cannabis capital raises decreased to $2.1 billion from $2.3 billion in 2024, significantly lower than $4.3 billion in 2022[75] - Mergers and acquisitions activity in the North American regulated cannabis industry increased to approximately $2.1 billion in 2025, up from $1.2 billion in 2024[75] Tenant and Operational Risks - The company reported that inflation and supply chain constraints have negatively impacted tenant costs, leading to cost overruns and delays in project completions[73] - As of December 31, 2025, PharmaCann defaulted on rent obligations totaling $29.2 million across multiple leases, representing approximately 9.9% of the company's annualized contractual rent due[84] - The company declared defaults on leases with tenants accounting for approximately 11.6% of annualized contractual rent due, totaling $31.3 million[85] - The company expects many tenants to continue incurring losses in 2026, relying on cash on hand or asset sale proceeds for rent payments[80] - Many existing and future tenants are companies with limited operational histories, potentially unable to pay rent from operations, adversely affecting cash available for distributions[163] - The cannabis industry faces unfavorable market dynamics, impacting tenants' ability to make lease payments, leading to increased default rates[169] Regulatory and Compliance Challenges - The company operates in a highly regulated cannabis industry, requiring licenses for cultivation, processing, and dispensing, with local laws varying significantly[122] - There is a significant risk that federal authorities may enforce current federal law against cannabis, adversely affecting the company's business and financial condition[123] - Financial institutions face challenges in providing services to cannabis-related businesses due to federal laws, including the Bank Secrecy Act, which mandates reporting of suspicious activities[126] - The FinCEN Memorandum outlines requirements for financial institutions to serve cannabis businesses, but it is not legally binding and may be modified or rescinded at any time[130] - Many banks are hesitant to offer banking services to cannabis-related businesses, which could increase operational costs and pose logistical challenges for the company[131] Environmental and Operational Risks - The company’s properties are subject to various agricultural regulations, including water usage and chemical application, which could impact operational compliance and costs[135] - Environmental laws and regulations may impose significant costs and liabilities on the company, especially for properties repurposed for cannabis operations[142] - Changes in zoning and land use regulations could prevent the company from leasing properties for cannabis cultivation in the future[144] - Properties require adequate water and power supplies for cannabis cultivation; interruptions could adversely affect leasing and returns[218] - Indoor cannabis cultivation is power-intensive; power supply interruptions may harm tenant crops and affect lease payments, impacting cash flows[219] Strategic Growth and Competition - The company aims to maximize stockholder returns through regular distributions and sustainable long-term growth in cash flows driven by increased rents and disciplined portfolio expansion[53] - The company focuses on acquiring specialized industrial properties, particularly in states with established regulated cannabis programs, to generate stable and increasing rental income[58] - The current market for properties suitable for regulated cannabis operators is limited, with increased competition from various market participants[103] - The company faces competition from other companies, independent investors, and cannabis operators, which may lead to higher acquisition costs for desirable properties[106] - The company’s growth strategy focuses on acquiring specialized industrial real estate assets, particularly regulated cannabis facilities, but faces risks related to the ability to consummate acquisitions on advantageous terms[196] Legal and Litigation Risks - The company is currently subject to securities lawsuits and an SEC investigation, which may divert management's attention and adversely affect financial condition[185] - The company has not established reserves for potential liabilities related to pending litigation or SEC investigations, which could adversely affect cash flows[189] Future Outlook and Concerns - The company’s independent auditor expressed substantial doubt about its ability to continue as a going concern without refinancing or additional financing[162] - Rising interest rates could increase capital costs and reduce investment returns, adversely affecting distributions to shareholders[162] - The company’s property portfolio is geographically concentrated, increasing risk exposure to local market conditions[158] - Changes in federal regulations could lead to increased access to capital markets for competitors, impacting the company's competitive position[194] - The impact of global pandemics on operations and tenant businesses remains uncertain, potentially affecting cash flows and distributions to stockholders[199]

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2025 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _________ to _______ Commission File No. 001-38911 CLARIVATE PLC (Exact name of registrant as specified in its charter) Jersey, Channel Islands Not applicable (State or other ju ...

Clarivate Reports Fourth Quarter and Full Year 2025 Results — Value Creation Plan accelerated organic ACV and drove higher cash flow in 2025 — — Financial outlook for 2026 projects continued momentum — — Provides update on strategic review; Currently engaged in active discussions with interested parties to sell Life Sciences & Healthcare business — London, UK -- February 24, 2026 Clarivate Plc (NYSE: CLVT) (the "Company" or "Clarivate"), a leading global provider of transformative intelligence, today report ...

Exhibit 99.1 Armstrong World Industries Reports Record-Setting Fourth-Quarter and Full-Year 2025 Results Fourth-Quarter 2025 Full-Year 2025 LANCASTER, Pa., Feb. 24, 2026 -- Armstrong World Industries, Inc. (NYSE:AWI), an Americas leader in the design and manufacture of innovative interior and exterior architectural applications including ceilings, specialty walls and exterior metal solutions, today reported fourth-quarter and full- year 2025 financial results highlighted by strong sales and earnings growth ...